Meaningful Use Certification  
 
CERTIFICATION STATEMENT

"2011-2012 Certified UniCharts EMR version 3" by UnisonCare Corporation completed EHR certification on 09/15/2011 for the following:

Complete EHR Ambulatory

Clinical Quality Measures tested: NQF0001, NQF0002, NQF0004, NQF0012, NQF0013, NQF0014, NQF0018, NQF0024, NQF0027,NQF0028, NQF31, NQF0032, NQF0033, NQF0034, NQF0036, NQF0038, NQF0041, NQF0043, NQF0047, NQF0052, NQF0055, NQF0056, NQF0059, NQF0061, NQF0062, NQF0064, NQF0067, NQF0068, NQF0070, NQF0073, NQF0074, NQF0075, NQF0081, NQF0083, NQF0084, NQF0086, NQF0088, NQF0089, NQF0105, NQF0385, NQF0387, NQF0389, NQF0421, NQF0575
Additional software used: Allscripts ePrescribe; Email software

This Complete EHR certification is 2011/2012 compliant and has been certified by Drummond Group Inc., an ONC-ATCB, authorized to conduct complete and modular EHR testing and certification in accordance with the applicable certification criteria adopted by the Secretary of Health and Human Services. This certification does not represent an endorsement by the U.S. Department of Health and Human Services or guarantee the receipt of incentive payments.

Click here to download the certificate of compliance
Click here to view offical product listing maintained by the Office of the National Coordinator for Health Information Technology



The "2011-2012 Certified UniCharts EMR version 3" is certified for all of the 15 core and 10 elective requirements mentioned at the bottom of this page, making it 100% certified for Stage 1 Meaningful Use (with e-prescription through free nationalerx.com or any user preferred web-based service). Furthermore, UniCharts electronic medical records system in question has been certified to include All 44 Clinical Quality Measures, enabling eligible physicians and providers select the ones that best suit their specialty and workflow needs: These 44 measures are:

  1. NQF 0013 - Core - Hypertension: Blood Pressure Measurement
  2. NQF 0028 - Core - Preventive Care and Screening Measure Pair: (a) Tobacco Use Assessment, (b) Tobacco Cessation Intervention
  3. NQF 0421 (PQRI 128) - Core - Adult Weight Screening and Follow-Up
  4. NQF 0024 - Alternate Core - Weight Assessment and Counseling for Children and Adolescents
  5. NQF 0038 - Alternate Core - Childhood Immunization Status
  6. NQF 0041 (PQRI 110) - Alternate Core - Preventive Care and Screening: Influenza Immunization for Patients 50 Years or Older
  7. NQF 0001 (PQRI 64) - Additional - Asthma Assessment
  8. NQF 0002 (PQRI 66) - Additional - Appropriate Testing for Children with Pharyngitis
  9. NQF 0004 - Additional - Initiation and Engagement of Alcohol and Other Drug Dependence Treatment: (a) Initiation, (b) Engagement
  10. NQF 0012 - Additional - Prenatal Care: Screening for Human Immunodeficiency Virus (HIV)
  11. NQF 0014 - Additional - Prenatal Care: Anti-D Immune Globulin
  12. NQF 0018 - Additional - Controlling High Blood Pressure
  13. NQF 0027 (PQRI 115) - Additional - Smoking and Tobacco Use Cessation, Medical assistance: (a) Advising to Quit, (b) Discussing Cessation Medications, (c) Discussing Cessation Strategies
  14. NQF 0031 (PQRI 112) - Additional - Breast Cancer Screening
  15. NQF 0032 - Additional - Cervical Cancer Screening
  16. NQF 0033 - Additional - Chlamydia Screening for Women
  17. NQF 0034 (PQRI 113) - Additional - Colorectal Cancer Screening
  18. NQF 0036 - Additional - Use of Appropriate Medications for Asthma
  19. NQF 0043 (PQRI 111) - Additional - Pneumonia Vaccination Status for Older Adults
  20. NQF 0047 (PQRI 53) - Additional - Asthma Pharmacologic Therapy
  21. NQF 0052 - Additional - Low Back Pain: Use of Imaging Studies
  22. NQF 0055 (PQRI 117) - Additional - Diabetes: Eye Exam
  23. NQF 0056 (PQRI 163) - Additional - Diabetes: Foot Exam
  24. NQF 0059 (PQRI 1) - Additional - Diabetes: Hemoglobin A1c Poor Control
  25. NQF 0061 (PQRI 3) - Additional - Diabetes: Blood Pressure Management
  26. NQF 0062 (PQRI 119) - Additional - Diabetes: Urine Screening
  27. NQF 0064 (PQRI 2) - Additional - Diabetes: Low Density Lipoprotein (LDL) Management and Control
  28. NQF 0067 (PQRI 6) - Additional - Coronary Artery Disease (CAD): Oral Antiplatelet Therapy Prescribed for Patients with CAD
  29. NQF 0068 (PQRI 204) - Additional - Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic
  30. NQF 0070 (PQRI 7) - Additional - Coronary Artery Disease (CAD): Beta-Blocker Therapy for CAD Patients with Prior Myocardial Infarction (MI)
  31. NQF 0073 (PQRI 201) - Additional - Ischemic Vascular Disease (IVD): Blood Pressure Management
  32. NQF 0074 (PQRI 197) - Additional - Coronary Artery Disease (CAD): Drug Therapy for Lowering LDL Cholesterol
  33. NQF 0075 - Additional - Ischemic Vascular Disease (IVD): Complete Lipid Panel and LDL Control
  34. NQF 0081 (PQRI 5) - Additional - Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction (LVSD)
  35. NQF 0083 (PQRI 8) - Additional - Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)
  36. NQF 0084 (PQRI 200) - Additional - Heart Failure (HF): Warfarin Therapy Patients with Atrial Fibrillation
  37. NQF 0086 (PQRI 12) - Additional - Primary Open Angle Glaucoma (POAG): Optic Nerve Evaluation
  38. NQF 0088 (PQRI 18) - Additional - Diabetic Retinopathy: Documentation of Presence or Absence of Macular Edema and Level of Severity of Retinopathy
  39. NQF 0089 (PQRI 19) - Additional - Diabetic Retinopathy: Communication with the Physician Managing Ongoing Diabetes Care
  40. NQF 0105 (PQRI 9) - Additional - Anti-depressant medication management: (a) Effective Acute Phase Treatment, (b) Effective Continuation Phase Treatment
  41. NQF 0385 (PQRI 72) - Additional - Oncology Colon Cancer: Chemotherapy for Stage III Colon Cancer Patients
  42. NQF 0387 (PQRI 71) - Additional - Oncology Breast Cancer: Hormonal Therapy for Stage IC-IIIC Estrogen Receptor/Progesterone Receptor (ER/PR) Positive Breast Cancer
  43. NQF 0389 (PQRI 102) - Additional - Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients
  44. NQF 0575 - Additional - Diabetes: Hemoglobin A1c Control (<8.0%)

The 15 Core and 10 Elective requirements for meaningful use that certified UniCharts EHR would help you achieve:

  • The Core Set
    • Record patient demographics (sex, race, ethnicity, date of birth, preferred language). More than 50% of patients’ demographic data must be recorded as structured data.
    • Record vital signs and chart changes (height, weight, blood pressure, body mass index, growth charts for children). More than 50% of patients 2 years of age or older must have height, weight and blood pressure recorded as structured data.
    • Maintain up-to-date problem list of current and active diagnoses. More than 80% of patients must have at least one entry recorded as structured data.
    • Maintain an active medication list. More than 80% of patients must have at least one entry recorded as structured data.
    • Maintain an active medication allergy list. More than 80% of patients must have at least one entry recorded as structured data.
    • Record smoking status for patients 13 and older. More than 50% of patients age 13 or older must have smoking status recorded as structured data.
    • Provide patients with clinical summaries for each office visit. More than 50% of all visits must be provided with clinical summaries within 3 business days.
    • Upon request, provide patients with an electronic copy of their health information (including diagnostic test results, problem list, medication list, medication allergies). More than 50% of requesting patients must receive an electronic copy within 3 business days.
    • Generate and transmit permissible prescriptions electronically. More than 40% must be transmitted electronically using certified EMR technology.
    • Computerized Provider Order Entry for Medication Orders. More than 30% of patients with at least one medication in their medication list must have at least one medication ordered through CPOE.
    • Implement drug-drug and drug-allergy interaction checks. Functionality must be enabled for these checks for the entire reporting period.
    • Implement capability to electronically exchange key clinical information among providers and patient-authorized entities. Must perform at least one test of the EMR's capacity to electronically exchange information.
    • Implement one clinical decision support rule and track compliance with that rule. One rule must be implemented.
    • Implement systems to protect privacy and security of patient data in the EHR. Must conduct or review a security risk analysis, implement security updates as necessary and correct identified security deficiencies.
    • Report clinical quality measures to CMS or states. For 2011, provide aggregate numerator and denominator through attestation whereas for 2012, electronically submit measures.

  • The Menu Set
    • Implement drug formulary checks. Drug formulary check system must be implemented and access at least one internal or external drug formulary during the reporting period.
    • Incorporate clinical laboratory test results into EHRs as structured data. More than 40% of clinical laboratory test results are in positive/negative or numerical format and are incorporated into EHRs as structured data.
    • Generate lists of patients by specific conditions for use for quality improvement, reduction of disparities, research or outreach. Must generate one listing of patients with a specific condition.
    • Use EHR technology to identify patient-specific education resources and provide those to the patient as appropriate. More than 10% of patients are provided patient specific education resources.
    • Perform Medication reconciliation between care settings. Medication reconciliation must be performed for more than 50% of transitions of care.
    • Provide summary of care record for patients referred or transitioned to another provider or setting. Summary of care record must be provided for more than 50% of patient transitions or referrals.
    • Submission of electronic immunization data to immunization registries or immunization information systems. Must perform at least one test of data submission and follow-up submission (where registries can accept electronic data).
    • Submission of electronic syndrome surveillance data to public health agencies. Must perform at least one test of data submission and follow-up submission (where public health agencies can accept electronic data).
    • Send reminders to patients (as per patient preference) for preventative and follow-up care. More than 20% of patients aged 65 or older or age 5 or younger must be sent appropriate reminders.
    • Provide patients with timely electronic access to their health information (including laboratory results, problem list, medication list, medication allergies). More than 10% of patients must be provided with electronic access to information within 4 days of its being updated in the EHR.


UnisonCare Corporation 2003 - 2013. All Rights Reserved.